Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ViKnight: Vitamin K2 for Nocturnal Leg Cramps (Real-World Study)
ChiCTR2500106282Phase 4Recruiting
- Sponsor
- Third People's Hospital of Chengdu
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of menaquinone in nocturnal leg cramp (NLC), sponsored by Third People's Hospital of Chengdu. Primary endpoint: Symptom improvement rate at week 8. Started Jul 2025; status: recruiting.
02
Drugs
menaquinone
03
Conditions
nocturnal leg cramp (NLC)
Beyond the preview
Go deeper on ChiCTR2500106282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106282.